Detalles de la búsqueda
1.
How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users' guide.
Br J Dermatol
; 190(4): 527-535, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123134
2.
A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
Br J Dermatol
; 190(3): 392-401, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952167
3.
The Harmonising Outcome Measures for Eczema (HOME) implementation roadmap.
Br J Dermatol
; 189(6): 710-718, 2023 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548315
4.
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce.
J Eur Acad Dermatol Venereol
; 37(1): 123-136, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36018221
5.
The HOME Core outcome set for clinical trials of atopic dermatitis.
J Allergy Clin Immunol
; 149(6): 1899-1911, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35351441
6.
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
J Am Acad Dermatol
; 83(5): 1375-1384, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32485210
7.
Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.
J Am Acad Dermatol
; 82(5): 1181-1186, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31926221
8.
Reporting of Harmonising Outcome Measures for Eczema (HOME) core outcome set instruments in randomized clinical trials for systemic treatments in atopic dermatitis.
Br J Dermatol
; 189(4): 494-496, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434297
9.
Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'".
J Am Acad Dermatol
; 85(3): e173-e174, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33675862
10.
The wide variety of methotrexate dosing regimens for the treatment of atopic dermatitis: a systematic review.
J Dermatolog Treat
; 35(1): 2292962, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38124505
11.
The "Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)" Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum.
Arch Dermatol Res
; 315(4): 983-988, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305958
12.
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study.
J Dermatolog Treat
; 34(1): 2193663, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098906
13.
Minimum data set for treatment effectiveness in pyoderma gangrenosum (MIDSTEP): an international protocol of an e-Delphi study to develop a clinical physician-driven treatment effectiveness registry on behalf of the UPGRADE initiative.
Arch Dermatol Res
; 315(10): 2913-2919, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37755505
14.
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types.
JAAD Int
; 10: 14-24, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36387062
15.
Consensus on the therapeutic management of atopic dermatitis â Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique.
An Bras Dermatol
; 98(6): 814-836, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37302894
16.
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
JAMA Dermatol
; 158(12): 1429-1435, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223090
17.
On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? - a systematic review with GRADE approach.
J Dermatolog Treat
; 33(4): 1947-1966, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34425719
18.
Work ability and quality of working life in atopic dermatitis patients treated with dupilumab.
J Dermatol
; 48(9): 1305-1314, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34013539
19.
Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique
An. bras. dermatol
; 98(6): 814-836, 2023. tab, graf
Artículo
en Inglés
|
LILACS-Express
| ID: biblio-1520040
20.
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
Trials
; 18(1): 87, 2017 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28241851